http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3119987-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf9cb42a1081907fb01b7424db35ddab
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498
filingDate 2021-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_baf185bad85657646f9ed8a911441c2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcabab31548d936d05b24325995d5446
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a114b53d8f483f032689f9ed77539d0
publicationDate 2022-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-3119987-A1
titleOfInvention Hydrogel composition and uses thereof in the prevention and/or treatment of radiation damage to the skin
abstract The invention relates to a composition in a form suitable for topical water-based administration comprising a vasoconstrictor. The invention is characterized in that the composition comprises a vasoconstrictor chosen from brimonidine or its salts, in a solvent phase comprising: - polyethylene glycol in combination with propylene glycol and/or dimethyl sulphoxide (DMSO); - a Polyvinylpyrrolidone/Vinyl Acetate copolymer as a hydrophilic film-forming agent; - glycerin; and in that it is in the form of a hydrogel. The invention also relates to the composition according to the invention for its use as a medicament, more particularly in the prevention and/or treatment of dermatitis resulting from radiation, in particular in the context of radiotherapy treatment.n Figure 9
priorityDate 2021-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020121675-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416290180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414161244

Total number of triples: 25.